Current Report Filing (8-k)
December 11 2017 - 1:27PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of Report (Date of earliest event reported):
December 11, 2017
MEDICAL
TRANSCRIPTION BILLING, CORP.
(Exact name of registrant as specified in its charter)
Delaware
|
|
001-36529
|
|
22-3832302
|
(State
or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(IRS
Employer
Identification No.)
|
7
Clyde Road, Somerset, New Jersey, 08873
(Address of principal executive offices, zip code)
(732)
873-5133
(Registrant’s
telephone number, including area code)
Not
Applicable
(Former name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company [X]
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [X]
Item
1.01 Entry into a Material Definitive Agreement
On
December 7, 2017, Medical Transcription Billing, Corp. (“MTBC” or the “Company”) entered into a Placement
Agency Agreement (the “Agreement”) with H.C. Wainwright & Co., LLC pursuant to which the Company agreed to issue
and sell 155,440 shares of its 11% Series A Cumulative Redeemable Preferred Stock in a public offering pursuant to a Registration
Statement on Form S-3 (File No. 333-210391) and a related prospectus, including the related prospectus supplement, filed with
the Securities and Exchange Commission.
The
net proceeds of the offering to the Company were approximately $3.4 million, after deducting placement agency fees and other estimated
offering expenses. The Agreement is filed as Exhibit 1.1 to this Current Report on Form 8-K and is incorporated herein by reference.
The Company issued a press release announcing the closing of the public offering, a copy of which is attached hereto as Exhibit
99.1 and incorporated herein by reference.
Item
8.01 Other Events
In
connection with the offering referenced above, the legal opinion as to the legality of the series A preferred stock sold is being
filed as Exhibit 5.1 to this Current Report on Form 8-K and is incorporated herein and into the Registration Statement by reference.
Item
9.01 Financial Statements and Exhibits
SIGNATURE(S)
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, hereunto duly authorized.
|
Medical
Transcription Billing, Corp.
|
|
|
Date:
December 11, 2017
|
By:
|
/s/
Mahmud Haq
|
|
|
Mahmud
Haq
|
|
|
Chairman
of the Board and Chief Executive Officer
|
CareCloud (NASDAQ:MTBCP)
Historical Stock Chart
From Jun 2024 to Jul 2024
CareCloud (NASDAQ:MTBCP)
Historical Stock Chart
From Jul 2023 to Jul 2024